<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03976960</url>
  </required_header>
  <id_info>
    <org_study_id>BCB2014/01</org_study_id>
    <nct_id>NCT03976960</nct_id>
  </id_info>
  <brief_title>Clinical and Biological Database in Colon Cancer and Colic Tumors</brief_title>
  <acronym>BCBCOLON</acronym>
  <official_title>Prospective, Multicenter, Clinical and Biological Database Set-up in Colon Cancer and Colic Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut du Cancer de Montpellier - Val d'Aurelle</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut du Cancer de Montpellier - Val d'Aurelle</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Developement of a clinical and biological database in colon cancer and colic tumors in order&#xD;
      to better understand tumor invasion and metastatic scattering processes. The investigators&#xD;
      hope that a better understanding of tumoral invasion process will lead to the discovery of&#xD;
      new biomarkers and new drugs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As the second leading cause of cancer-related death in France, colorectal cancer is a major&#xD;
      public health problem. Each year, 37 000 cases are newly diagnosed in France and 17 000&#xD;
      patients die of the disease.&#xD;
&#xD;
      Colorectal cancer is due to molecular and genetic damages involved in all tumorigenesis&#xD;
      steps, transition from healthy tissue to adenoma and finally to invasive carcinoma stage. The&#xD;
      investigators hope that a to better understand tumor invasion and metastatic scattering&#xD;
      processes will allow therapeutic innovation and the emergence of new biomarkers.&#xD;
&#xD;
      However, the study of early tumorigenesis phases as well as advanced stages of the disease is&#xD;
      currently limited due to a lack of tissue samples.&#xD;
&#xD;
      In this context, the Montpellier Cancer Institute (ICM) decided to initiate a biological&#xD;
      collection dedicated to the tissular and blood samples of patients with colorectal cancer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 19, 2018</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of clinical risk factors for colorectal cancer</measure>
    <time_frame>Until the study completion : 6 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of biological risk factors for colorectal cancer</measure>
    <time_frame>Until the study completion : 6 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Cancer Colon</condition>
  <arm_group>
    <arm_group_label>Biological collection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For all the patients include in the study :&#xD;
samples of blood samples collected before or after surgery but also samples in paraffin-embedded tissue sections.&#xD;
In parallel to this biological collection, standardized clinical data will be entered into a database</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biological collection</intervention_name>
    <description>The biological collection will also include samples of blood samples collected before or after surgery but also samples frozen and/or paraffin-embedded tissue sections.</description>
    <arm_group_label>Biological collection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient undergoing colon cancer surgery (stage I, II, III and IV)&#xD;
&#xD;
          2. Patient operated for liver or lung or peritoneal carcinomatosis metastases originating&#xD;
             from colon cancer&#xD;
&#xD;
          3. Patient operated for pre-neoplastic lesion (adenomatous polyp /villous adenoma polyp),&#xD;
&#xD;
          4. Patient with familial polyposis eligible for colectomy&#xD;
&#xD;
          5. Age &gt; 18 years&#xD;
&#xD;
          6. Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient not affiliated to Social Protection system&#xD;
&#xD;
          2. Patient unable to understand or comply with study instructions or requirements for&#xD;
             psychological, family, social or geographical reasons&#xD;
&#xD;
          3. Patient under guardianship&#xD;
&#xD;
          4. Minor patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ERIC ASSENAT, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Institut régional du cancer de Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Pierre BLEUSE, M.D</last_name>
    <phone>4 67 61 31 02</phone>
    <phone_ext>+ 33</phone_ext>
    <email>DRCI-icm105@icm.unicancer.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <state>Hérault</state>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Assénat, MD</last_name>
      <phone>467330137</phone>
      <phone_ext>+33</phone_ext>
      <email>e-assenat@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Régional du cancer de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ERIC ASSENAT, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://www.google.com/search?client=firefox-b-d&amp;sxsrf=ALeKk0251JuQRT2bZiWL8ut7KwGhX0TKeQ:1596454499279&amp;q=Estimation+nationale+de+l%27incidence+et+de+la+mortalit%C3%A9+par+cancer+en+France+entre+1980+et+2012.+Partie+1-+Tumeurs+solides.+Traitement+:+INCA+2013.&amp;spell=1&amp;sa=X&amp;ved=2ahUKEwj7lNG6-P7qAhVKxIUKHZeSCMMQBSgAegQICxAq&amp;biw=1920&amp;bih=1006</url>
    <description>National estimate of cancer incidence and mortality in France between 1980 and 2012.</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 5, 2019</study_first_submitted>
  <study_first_submitted_qc>June 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>colon</keyword>
  <keyword>tumor</keyword>
  <keyword>colic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Colic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

